Atlas Principals, LLC Gilead Sciences, Inc. Call Options Transaction History

Atlas Principals, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $7.97 Million - $8.7 Million	-125,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $5.13 Million - $5.85 Million	85,500 Added 213.75%	125,500 $8.11 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.27 Million - $2.58 Million	40,000 New	40,000 $2.33 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $7.52 Million - $9.63 Million	-120,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $7.39 Million - $8.13 Million	120,000 New	120,000 $7.8 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Atlas Principals, LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Principals, LLC with notifications on news.